Essex Financial Services, Inc. Abb Vie Inc. Transaction History

Essex Financial Services, Inc.

$2.07 Billion
Q3 2024

A detailed history of Essex Financial Services, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Essex Financial Services, Inc. holds 37,704 shares of ABBV stock, worth $6.67 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

37,704

Previous 37,887 0.48%

Holding current value

$6.67 Million

Previous $6.5 Million 14.57%

% of portfolio

0.36%

Previous 0.32%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$163.84 - $199.33 $29,982 - $36,477	-183 Reduced 0.48%	37,704 $7.45 Million
Q2 2024 Aug 09, 2024	SELL	$154.79 - $180.76 $15,479 - $18,076	-100 Reduced 0.26%	37,887 $6.5 Million
Q2 2024 Jul 31, 2024	BUY	$154.79 - $180.76 $1.22 Million - $1.43 Million	7,913 Added 26.31%	37,987 $6.52 Million
Q1 2024 Apr 23, 2024	BUY	$159.82 - $182.1 $211,921 - $241,464	1,326 Added 4.61%	30,074 $5.48 Million
Q4 2023 Feb 05, 2024	BUY	$137.6 - $154.97 $3,027 - $3,409	22 Added 0.08%	28,748 $4.46 Million
Q3 2023 Nov 15, 2023	BUY	$133.59 - $154.65 $21,507 - $24,898	161 Added 0.56%	28,726 $4.28 Million
Q2 2023 Aug 08, 2023	SELL	$132.51 - $164.9 $416,611 - $518,445	-3,144 Reduced 9.92%	28,565 $3.85 Million
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $897,594 - $1.03 Million	-6,207 Reduced 16.37%	31,709 $5.05 Million
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $21,852 - $26,207	-158 Reduced 0.41%	37,916 $6.13 Million
Q3 2022 Nov 07, 2022	BUY	$134.21 - $153.93 $287,612 - $329,871	2,143 Added 5.96%	38,074 $5.11 Million
Q2 2022 Aug 01, 2022	BUY	$137.62 - $174.96 $35,093 - $44,614	255 Added 0.71%	35,931 $5.5 Million
Q1 2022 Apr 21, 2022	BUY	$131.98 - $163.75 $39,857 - $49,452	302 Added 0.85%	35,676 $5.78 Million
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $381,054 - $482,143	-3,547 Reduced 9.11%	35,374 $4.79 Million
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $1.27 Million - $1.45 Million	11,969 Added 44.41%	38,921 $4.13 Million
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $103,220 - $113,633	-1,009 Reduced 3.61%	26,952 $2.92 Million
Q4 2020 Feb 05, 2021	BUY	$80.49 - $108.67 $135,223 - $182,565	1,680 Added 6.39%	27,961 $3 Million
Q3 2020 Nov 10, 2020	BUY	$85.91 - $100.83 $64,088 - $75,219	746 Added 2.92%	26,281 $2.35 Million
Q2 2020 Aug 06, 2020	SELL	$73.37 - $98.18 $16,875 - $22,581	-230 Reduced 0.89%	25,535 $2.51 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $231,490 - $350,968	-3,589 Reduced 12.23%	25,765 $1.96 Million
Q4 2019 Jan 30, 2020	BUY	$72.13 - $90.25 $93,480 - $116,964	1,296 Added 4.62%	29,354 $2.6 Million
Q3 2019 Nov 04, 2019	SELL	$62.98 - $75.72 $32,623 - $39,222	-518 Reduced 1.81%	28,058 $2.13 Million
Q2 2019 Jul 30, 2019	BUY	$65.7 - $83.98 $7,884 - $10,077	120 Added 0.42%	28,576 $2.08 Million
Q1 2019 May 02, 2019	SELL	$77.14 - $90.79 $40,344 - $47,483	-523 Reduced 1.8%	28,456 $2.29 Million
Q4 2018 Feb 07, 2019	SELL	$77.85 - $96.01 $594,540 - $733,228	-7,637 Reduced 20.86%	28,979 $2.67 Million
Q3 2018 Nov 05, 2018	BUY	$88.91 - $98.84 $27,384 - $30,442	308 Added 0.85%	36,616 $3.46 Million
Q2 2018 Aug 07, 2018	SELL	$89.78 - $106.23 $36,630 - $43,341	-408 Reduced 1.11%	36,308 $3.36 Million
Q1 2018 May 03, 2018	BUY	$92.01 - $123.21 $26,590 - $35,607	289 Added 0.79%	36,716 $3.48 Million
Q4 2017 Feb 07, 2018	SELL	$89.56 - $98.21 $21,583 - $23,668	-241 Reduced 0.66%	36,427 $3.52 Million
Q3 2017 Nov 03, 2017	BUY	$69.85 - $89.22 $12,852 - $16,416	184 Added 0.5%	36,668 $3.26 Million
Q2 2017 Aug 07, 2017	BUY	N/A	36,484	36,484 $2.65 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Essex Financial Services, Inc. with notifications on news.

Account

Essex Financial Services, Inc. Abb Vie Inc. Transaction History